81 filings
10-Q
2024 Q1
DERM
Journey Medical Corp
Quarterly report
14 May 24
4:46pm
8-K
DERM
Journey Medical Corp
13 May 24
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
4:05pm
8-K
DERM
Journey Medical Corp
1 May 24
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
4:05pm
DEFA14A
DERM
Journey Medical Corp
29 Apr 24
Additional proxy soliciting materials
4:08pm
DEF 14A
DERM
Journey Medical Corp
Definitive proxy
29 Apr 24
4:06pm
8-K
ki2myh
21 Mar 24
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
4:20pm
8-K
bex1n
2 Jan 24
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
4:05pm
S-8
3hu 7cql5
15 Dec 23
Registration of securities for employees
4:46pm
8-K
la2pgxmxf1uwl6
8 Dec 23
Departure of Directors or Certain Officers
5:01pm
8-K
s6bqxh1dldzl4h2d
7 Nov 23
Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
4:45pm
8-K
lgbkqqat94zh5mg
26 Sep 23
Other Events
9:10am
8-K
08hp3pdpad05
19 Sep 23
Other Events
4:59pm
8-K
ggj7y
6 Sep 23
Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations
8:00am
8-K
9yb 5epvyduyw3q9
18 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
mx74o1
8 Aug 23
Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:06pm
8-K
nbfnsb2 86
26 Jul 23
Other Events
8:30am
8-K
a7ougrto9
23 Jun 23
Departure of Directors or Certain Officers
4:05pm